ICON plc
Leopardstown/Dublin/Ireland
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies.
With headquarters in Dublin, Ireland, ICON currently operates from 79 locations in 38 countries and has over 8,300 employees. Over 1,000 of these employees are based in 14 different countries throughout Asia Pacific. ICON Clinical Research specialises in the planning management, execution and analysis of Phase IIb – IV clinical trials, ranging from small studies to complex, multinational projects.
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programmes that support clinical development – from compound selection to phase I–IV clinical studies. We have the capability and expertise to conduct clinical trials and development projects on either a local or global basis.
Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programmes.
• Phase I–IV Clinical-trial Design, Management and Review
• Clinical Pharmacology
• Bioanalytical Laboratory Services
• Clinical Pathology
• Protocol Design
• Biomarker Services
• Pharmacodynamic/Pharmacokinetic Analysis
• Data Management and Biostatistics
• Medical and Safety Services
• Interactive Technologies
• Patient Recruitment
• Medical Imaging
• Global Central Laboratory Services
• Medical Writing and Communications
• Programme Management
• Resourcing Solutions
With headquarters in Dublin, Ireland, ICON currently operates from 79 locations in 38 countries and has over 8,300 employees. Over 1,000 of these employees are based in 14 different countries throughout Asia Pacific. ICON Clinical Research specialises in the planning management, execution and analysis of Phase IIb – IV clinical trials, ranging from small studies to complex, multinational projects.
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programmes that support clinical development – from compound selection to phase I–IV clinical studies. We have the capability and expertise to conduct clinical trials and development projects on either a local or global basis.
Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programmes.
• Phase I–IV Clinical-trial Design, Management and Review
• Clinical Pharmacology
• Bioanalytical Laboratory Services
• Clinical Pathology
• Protocol Design
• Biomarker Services
• Pharmacodynamic/Pharmacokinetic Analysis
• Data Management and Biostatistics
• Medical and Safety Services
• Interactive Technologies
• Patient Recruitment
• Medical Imaging
• Global Central Laboratory Services
• Medical Writing and Communications
• Programme Management
• Resourcing Solutions